TY - JOUR
T1 - Physicochemical study on microencapsulation of hydroxypropyl-β- cyclodextrin in dermal preparations
AU - Al-Rawashdeh, Nathir A.F.
AU - Al-Sadeh, Khaled S.
AU - Al-Bitar, Mohammad Bassam
N1 - Funding Information:
Financial support by Deanship of Research at Jordan University of Science and Technology (grant number 30/2003) is deeply appreciated. The authors are indebted to Physikalische Chemie I, Ruhr-University at Bochum, Germany, for their help in SEM measurements.
PY - 2010/6
Y1 - 2010/6
N2 - Objective: To investigate the effect of hydroxypropyl-β-cyclodextrin (HP-β-CD) concentration on the physicochemical properties of the sunscreen agents, namely oxybenzone (Oxy), octocrylene (Oct), and ethylhexyl-methoxy- cinnamate (Cin), in aqueous solution and cream formulations. Methods: The inclusion complexes of sunscreen agents with hydroxypropyl-β-cyclodextrin (HP-β-CD) in aqueous solution and solid phase were studied by UV-vis spectrophotmetery, differential scanning calorimetry (DSC), scanning electron microscopy (SEM), and 13C-NMR techniques. The photodegradation reaction of the sunscreen agents' molecules in lotion was explored using UV-vis spectrophotometry and high-performance liquid chromatography (HPLC). Results: The formation of the inclusion complexes was confirmed experimentally using DSC, SEM, and 13C-NMR. The results of spectrophotometric and HPLC studies have shown that the inclusion complexation with HP-β-CD has the potential to enhance the photostability of the selected sunscreen agents in lotion. HPLC results indicated that HP-β-CD has approximately increases the photostability of Oct by six- to eightfold. Moreover, the presence of HP-β-CD in lotion controlled the isomerization process of Cin to a certain degree, which was found to be a function of the amount of HP-β-CD added. Conclusions: It has been demonstrated that the photostability of the tested sunscreen agents has been enhanced upon forming inclusion complexes with HP-β-CD in lotion. The results of this study demonstrate that HP-β-CD can be utilized as photostabilizer additive for enhancing the photostability of the sunscreen agents' molecules.
AB - Objective: To investigate the effect of hydroxypropyl-β-cyclodextrin (HP-β-CD) concentration on the physicochemical properties of the sunscreen agents, namely oxybenzone (Oxy), octocrylene (Oct), and ethylhexyl-methoxy- cinnamate (Cin), in aqueous solution and cream formulations. Methods: The inclusion complexes of sunscreen agents with hydroxypropyl-β-cyclodextrin (HP-β-CD) in aqueous solution and solid phase were studied by UV-vis spectrophotmetery, differential scanning calorimetry (DSC), scanning electron microscopy (SEM), and 13C-NMR techniques. The photodegradation reaction of the sunscreen agents' molecules in lotion was explored using UV-vis spectrophotometry and high-performance liquid chromatography (HPLC). Results: The formation of the inclusion complexes was confirmed experimentally using DSC, SEM, and 13C-NMR. The results of spectrophotometric and HPLC studies have shown that the inclusion complexation with HP-β-CD has the potential to enhance the photostability of the selected sunscreen agents in lotion. HPLC results indicated that HP-β-CD has approximately increases the photostability of Oct by six- to eightfold. Moreover, the presence of HP-β-CD in lotion controlled the isomerization process of Cin to a certain degree, which was found to be a function of the amount of HP-β-CD added. Conclusions: It has been demonstrated that the photostability of the tested sunscreen agents has been enhanced upon forming inclusion complexes with HP-β-CD in lotion. The results of this study demonstrate that HP-β-CD can be utilized as photostabilizer additive for enhancing the photostability of the sunscreen agents' molecules.
KW - Dermal preparations
KW - Hydroxypropyl-β-cyclodextrin
KW - Inclusion complex
KW - Photostability
KW - Sunscreen filters
UR - http://www.scopus.com/inward/record.url?scp=77952511908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77952511908&partnerID=8YFLogxK
U2 - 10.3109/03639040903449738
DO - 10.3109/03639040903449738
M3 - Article
C2 - 20050724
AN - SCOPUS:77952511908
SN - 0363-9045
VL - 36
SP - 688
EP - 697
JO - Drug Development and Industrial Pharmacy
JF - Drug Development and Industrial Pharmacy
IS - 6
ER -